Evaluation of Effect of β-Glucan on Cancer Cell Lines In vitro

Authors

  • Hiba Muhammed Al-Khuzaay Department of Biology, College of Science, Mustansiriyah University, 10052 Baghdad, IRAQ. https://orcid.org/0000-0001-8989-0254
  • Yasir Hussein Al-Juraisy Department of Biology, College of Science, Mustansiriyah University, 10052 Baghdad, IRAQ.
  • Ali Hussein Alwan Iraqi Center for Cancer and Medical Genetics Research, Mustansiriyah University, 10001 Baghdad, IRAQ.
  • Ehab Tousson Zoology department, Faculty of Science, Tanta University, EGYPT.

DOI:

https://doi.org/10.23851/mjs.v35i1.1387

Keywords:

β-glucan, MTT, Anticancer, AMJ13, MCF-7

Abstract

β-Glucan is linear polysaccharides containing d-glucose monomers connected by β-glycosidic linkages. Their structural variances are the result of several sources. This research project was designed to assess the anticancer activity by using β-glucan. The in vitro experiment employed breast cancer cell lines from Michigan Cancer Foundation-7 (MCF-7) and Ahmed, Murtudha, Jabriyah, 2013 (AMJ13). After 24, 48, and 72 hours in micro titration plate under completely sterile condition. Different concentrations of β-glucan (31.25, 62.5, 125, 250, 500, and 1000 μg/mL) were applied to the cancer cell lines. The MTT assay was used to check whether the cells had been inhibited. Cell viability in MCF7 and AMJ13 cells was significantly reduced by β-glucan. β-Glucan showed concentration and time-dependent growth inhibitory effects. The higher concentrations of β-glucan significantly (P<0.05) decrease the growth rate of cells, indicating that the higher concentrations were more effective at inhibiting growth.

Downloads

Download data is not yet available.

References

J. Ferlay, M. Ervik, F. Lam, M. Colombet, L. Mery & M. Piñeros, Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer, 2022.

H. M. Al-Khuzaay, Y. H. Aljuraisy & M. M. Al-Halbosiy, The activity of aqueous extracts of leaves and roots of dandelion on cancer cell lines. Plant archive, 2019, vol. 19, no. 2, pp. 3933-3936

WHO-fact sheet. 2021.

N. Lemonnier, G. B. Zhou, B. Prasher, M. Mukerji, Z. Chen, S. K. Brahmachari, D. Noble, C. Auffray & M. Sagner, Traditional Knowledge-based Medicine: A Review of History, Principles, and Relevance in the Present Context of P4 Systems Medicine. Prog. Prev. Med. 2017, vol. 2, e0011.

CrossRef

A. M. Zimmermann-Klemd, J. K. Reinhardt, M. Winker & C. Gründemann, Phytotherapy in Integrative Oncology-An Update of Promising Treatment Options. Molecules, 2022, vol. 27, no. 10, pp. 3209.

CrossRef | PubMed

E. J. Murphy, E. Rezoagli, I. Major, N. J. Rowan & J. G. Laffey, β-Glucan metabolic and immunomodulatory properties and potential for clinical application. J. Fungi, 2020, vol. 6, pp. 356.

CrossRef | PubMed

A. Z. Al-Saffar, A. F. Al-Shanon, S. L. Al-Brazanchi, F. A. Sabry, F. Hassan & N. A. Hadi, Phytochemical Analysis, Antioxidant and Cytotoxic Potentials of Pelargonium graveolens Extract in Human Breast Adenocarcinoma (MCF-7) Cell Line. Asian Journal of Biochemistry, 2017, vol. 12, no. 1, pp.16-26.

CrossRef

N. Wang, H. Liu, G. Liu, M. Li, X. He, C. Yin, Q. Tu, X. Shen, W. Bai, Q. Wang, Y. Tao & H. Yin, Yeast β-D-glucan exerts antitumor activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis. Redox Biol, 2020, vol. 32, pp. 101495.

CrossRef | PubMed

SAS. 2018. Statistical Analysis System, User's Guide. Statistical. Version 9.6th ed. SAS. Inst. Inc. Cary. N.C. USA.

A. Choromanska, J. Kulbacka, J. Harasym, R. Oledzki, A. Szewczyk & J. Saczko, High- and low-Molecular Weight oat Beta-Glucan Reveals Antitumor Activity in Human Epithelial Lung Cancer. Pathol. Oncol. Res, 2018, vol. 24, pp. 583-592.

CrossRef | PubMed

F. Peymaeei, F. Sadeghi & M. Roudbary, Candida albicans Beta-Glucan Induce Anti- Cancer Activity of Mesenchymal Stem Cells against Lung Cancer Cell Line: An In-Vitro Experimental Study. Asian Pac J Cancer Prev, 2020, vol. 21, no. 3, pp. 837-843.

CrossRef | PubMed

C. P. Matos, Z. Adiguzel, Y. Yildizhan, B. Cevatemre, T. B. Onder, O. Cevik, P. Nunes, L. P. Ferreira, M. D. Carvalho, D. L.Campos, F. R. Pavan, J. C. Pessoa, M. H. Garcia, A. I. Tomaz, I. Correia & C. Acilan, May iron (III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents. Eur J Med Chem. 2019, vol. 176, pp. 492-512.

CrossRef | PubMed

J. H. Hong & H. K. Jung, Antioxidant and antitumor activities of β-glucan rich. Exopolysaccharides with different molecular weight from Paenibacillus polymyxa JB115. Korean Soc Appl Biol Chem, 2014, vol. 57, pp. 105-112.

CrossRef

M. J. Kim, S. Y. Hong, S. K. Kim, C. H. Cheong, H. J. Park, H. K. Chun, K. H. Jang, B. D. Yoon, C. H. Kim & S. A. Kang, β-Glucan enhanced apoptosis in human colon cancer cells SNU-C4. Nutrion Res an Practice, 2009, vol. 3, pp. 180-184.

CrossRef | PubMed

Downloads

Key Dates

Received

05-05-2023

Revised

12-07-2023

Accepted

16-07-2023

Published

30-03-2024

Issue

Section

Original Article

How to Cite

[1]
H. M. Al-Khuzaay, Y. H. . Al-Juraisy, A. H. Alwan, and E. Tousson, “Evaluation of Effect of β-Glucan on Cancer Cell Lines In vitro”, Al-Mustansiriyah Journal of Science, vol. 35, no. 1, pp. 17–20, Mar. 2024, doi: 10.23851/mjs.v35i1.1387.

Similar Articles

11-20 of 99

You may also start an advanced similarity search for this article.